Literature DB >> 25037221

Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development.

Karin M Kirschner1, Julian F W Braun1, Charlotte L Jacobi1, Lucas J Rudigier1, Anja Bondke Persson1, Holger Scholz2.   

Abstract

Amine oxidase copper-containing 1 (AOC1; formerly known as amiloride-binding protein 1) is a secreted glycoprotein that catalyzes the degradation of putrescine and histamine. Polyamines and their diamine precursor putrescine are ubiquitous to all organisms and fulfill pivotal functions in cell growth and proliferation. Despite the importance of AOC1 in regulating polyamine breakdown, very little is known about the molecular mechanisms that control its expression. We report here that the Wilms tumor protein, WT1, which is necessary for normal kidney development, activates transcription of the AOC1 gene. Expression of a firefly luciferase reporter under control of the proximal AOC1 promoter was significantly enhanced by co-transfection of a WT1 expression construct. Binding of WT1 protein to a cis-regulatory element in the AOC1 promoter was confirmed by electrophoretic mobility shift assay and chromatin immunoprecipitation. Antisense inhibition of WT1 protein translation strongly reduced Aoc1 transcripts in cultured murine embryonic kidneys and gonads. Aoc1 mRNA levels correlated with WT1 protein in several cell lines. Double immunofluorescent staining revealed a co-expression of WT1 and AOC1 proteins in the developing genitourinary system of mice and rats. Strikingly, induced changes in polyamine homeostasis affected branching morphogenesis of cultured murine embryonic kidneys in a developmental stage-specific manner. These findings suggest that WT1-dependent control of polyamine breakdown, which is mediated by changes in AOC1 expression, has a role in kidney organogenesis.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Development; Gene Expression; Polyamine; Transcription Regulation; Tumor Suppressor Gene

Mesh:

Substances:

Year:  2014        PMID: 25037221      PMCID: PMC4148871          DOI: 10.1074/jbc.M114.564336

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Purification and characterization of diamine oxidase from porcine kidney and intestine.

Authors:  H G Schwelberger; E Bodner
Journal:  Biochim Biophys Acta       Date:  1997-06-20

2.  The human gene for diamine oxidase, an amiloride binding protein. Molecular cloning, sequencing, and characterization of the promoter.

Authors:  O Chassande; S Renard; P Barbry; M Lazdunski
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

3.  Diamine oxidase is the amiloride-binding protein and is inhibited by amiloride analogues.

Authors:  W F Novotny; O Chassande; M Baker; M Lazdunski; P Barbry
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

4.  Purification and characterization of diamine oxidase (histaminase) from rat small intestine.

Authors:  H Mizuguchi; I Imamura; M Takemura; H Fukui
Journal:  J Biochem       Date:  1994-09       Impact factor: 3.387

5.  Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1.

Authors:  J A Moshier; M Skunca; W Wu; S M Boppana; F J Rauscher; J Dosescu
Journal:  Nucleic Acids Res       Date:  1996-03-15       Impact factor: 16.971

6.  Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.

Authors:  D J Wolff; A Lubeskie
Journal:  Arch Biochem Biophys       Date:  1995-01-10       Impact factor: 4.013

Review 7.  Polyamines, chromatin structure and transcription.

Authors:  H R Matthews
Journal:  Bioessays       Date:  1993-08       Impact factor: 4.345

8.  High affinity binding sites for the Wilms' tumour suppressor protein WT1.

Authors:  T B Hamilton; K C Barilla; P J Romaniuk
Journal:  Nucleic Acids Res       Date:  1995-01-25       Impact factor: 16.971

9.  Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.

Authors:  S H Larsson; J P Charlieu; K Miyagawa; D Engelkamp; M Rassoulzadegan; A Ross; F Cuzin; V van Heyningen; N D Hastie
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

10.  WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.

Authors:  C Englert; X Hou; S Maheswaran; P Bennett; C Ngwu; G G Re; A J Garvin; M R Rosner; D A Haber
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  12 in total

1.  Wilms tumor protein-dependent transcription of VEGF receptor 2 and hypoxia regulate expression of the testis-promoting gene Sox9 in murine embryonic gonads.

Authors:  Karin M Kirschner; Lina K Sciesielski; Katharina Krueger; Holger Scholz
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

2.  CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk.

Authors:  Yi Chen; Yang Zhang; Zhihua Wang; Yewei Wang; Yujiao Luo; Nannan Sun; Shasha Zheng; Wenzhe Yan; Xiang Xiao; Sufang Liu; Ji Li; Hongling Peng; Yunxiao Xu; Guoyu Hu; Zhao Cheng; Guangsen Zhang
Journal:  Cell Death Dis       Date:  2022-07-07       Impact factor: 9.685

3.  Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.

Authors:  Yong Li; Peggy Sekula; Matthias Wuttke; Judith Wahrheit; Birgit Hausknecht; Ulla T Schultheiss; Wolfram Gronwald; Pascal Schlosser; Sara Tucci; Arif B Ekici; Ute Spiekerkoetter; Florian Kronenberg; Kai-Uwe Eckardt; Peter J Oefner; Anna Köttgen
Journal:  J Am Soc Nephrol       Date:  2018-03-15       Impact factor: 10.121

4.  Investigating the dysfunctional pathogenesis of Wilms' tumor through a multidimensional integration strategy.

Authors:  Wenbiao Chen; Jia Zhuang; Lan Gong; Yong Dai; Hongyan Diao
Journal:  Ann Transl Med       Date:  2019-04

5.  Increased AOC1 Expression Promotes Cancer Progression in Colorectal Cancer.

Authors:  Fangyuan Liu; Weijun Ou; Wenbo Tang; Zhenyu Huang; Zhehui Zhu; Wenjun Ding; Jihong Fu; Yilian Zhu; Chenying Liu; Weimin Xu; Peng Du
Journal:  Front Oncol       Date:  2021-05-05       Impact factor: 6.244

6.  WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1.

Authors:  Long Lv; Gong Chen; Jianping Zhou; Jun Li; Jianping Gong
Journal:  J Exp Clin Cancer Res       Date:  2015-10-13

7.  Patterns of gene expression characterize T1 and T3 clear cell renal cell carcinoma subtypes.

Authors:  Agnieszka M Borys; Michał Seweryn; Tomasz Gołąbek; Łukasz Bełch; Agnieszka Klimkowska; Justyna Totoń-Żurańska; Julita Machlowska; Piotr Chłosta; Krzysztof Okoń; Paweł P Wołkow
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

8.  Transcriptome Analysis of Rat Lungs Exposed to Moxa Smoke after Acute Toxicity Testing.

Authors:  Xiaoyu Xu; Wen Deng; Wanqing Zhang; Junhua Zhang; Muchen Wang; Si Shan; Hongning Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-18       Impact factor: 2.629

9.  Wt1 haploinsufficiency induces browning of epididymal fat and alleviates metabolic dysfunction in mice on high-fat diet.

Authors:  Karin M Kirschner; Anna Foryst-Ludwig; Sabrina Gohlke; Chen Li; Roberto E Flores; Ulrich Kintscher; Michael Schupp; Tim J Schulz; Holger Scholz
Journal:  Diabetologia       Date:  2021-11-30       Impact factor: 10.122

10.  AOC1 Contributes to Tumor Progression by Promoting the AKT and EMT Pathways in Gastric Cancer.

Authors:  Fen Xu; Yun Xu; Jian-Hui Xiong; Jing-Hui Zhang; Jian Wu; Jie Luo; Jian-Ping Xiong
Journal:  Cancer Manag Res       Date:  2020-03-10       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.